Standard
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. / Toustrup, Kasper; Sørensen, Brita Singers; Lassen, Pernille; Wiuf, Carsten; Alsner, Jan; Overgaard, Jens.
I:
Radiotherapy & Oncology, Bind 102, Nr. 1, 2012, s. 122-129.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Toustrup, K, Sørensen, BS, Lassen, P
, Wiuf, C, Alsner, J & Overgaard, J 2012, '
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck',
Radiotherapy & Oncology, bind 102, nr. 1, s. 122-129.
https://doi.org/10.1016/j.radonc.2011.09.010
APA
Toustrup, K., Sørensen, B. S., Lassen, P.
, Wiuf, C., Alsner, J., & Overgaard, J. (2012).
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
Radiotherapy & Oncology,
102(1), 122-129.
https://doi.org/10.1016/j.radonc.2011.09.010
Vancouver
Toustrup K, Sørensen BS, Lassen P
, Wiuf C, Alsner J, Overgaard J.
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
Radiotherapy & Oncology. 2012;102(1):122-129.
https://doi.org/10.1016/j.radonc.2011.09.010
Author
Toustrup, Kasper ; Sørensen, Brita Singers ; Lassen, Pernille ; Wiuf, Carsten ; Alsner, Jan ; Overgaard, Jens. / Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. I: Radiotherapy & Oncology. 2012 ; Bind 102, Nr. 1. s. 122-129.
Bibtex
@article{8917f9ab245b41babd8bc57ccdf31d8a,
title = "Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck",
abstract = "To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy.",
keywords = "Adult, Aged, Aged, 80 and over, Biopsy, Carcinoma, Squamous Cell, Cell Hypoxia, Chi-Square Distribution, Female, Gene Expression Regulation, Neoplastic, Head and Neck Neoplasms, Humans, Male, Middle Aged, Nimorazole, Predictive Value of Tests, Proportional Hazards Models, Radiation-Sensitizing Agents, Survival Rate, Tumor Markers, Biological",
author = "Kasper Toustrup and S{\o}rensen, {Brita Singers} and Pernille Lassen and Carsten Wiuf and Jan Alsner and Jens Overgaard",
note = "Copyright {\textcopyright} 2011 Elsevier Ireland Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.radonc.2011.09.010",
language = "English",
volume = "102",
pages = "122--129",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "1",
}
RIS
TY - JOUR
T1 - Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
AU - Toustrup, Kasper
AU - Sørensen, Brita Singers
AU - Lassen, Pernille
AU - Wiuf, Carsten
AU - Alsner, Jan
AU - Overgaard, Jens
N1 - Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
PY - 2012
Y1 - 2012
N2 - To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy.
AB - To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Biopsy
KW - Carcinoma, Squamous Cell
KW - Cell Hypoxia
KW - Chi-Square Distribution
KW - Female
KW - Gene Expression Regulation, Neoplastic
KW - Head and Neck Neoplasms
KW - Humans
KW - Male
KW - Middle Aged
KW - Nimorazole
KW - Predictive Value of Tests
KW - Proportional Hazards Models
KW - Radiation-Sensitizing Agents
KW - Survival Rate
KW - Tumor Markers, Biological
U2 - 10.1016/j.radonc.2011.09.010
DO - 10.1016/j.radonc.2011.09.010
M3 - Journal article
C2 - 21996521
VL - 102
SP - 122
EP - 129
JO - Radiotherapy & Oncology
JF - Radiotherapy & Oncology
SN - 0167-8140
IS - 1
ER -